NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 539 | 0.0% | 0.00% | – |
Q2 2023 | $0 | – | 539 | 0.0% | 0.00% | – |
Q1 2023 | $0 | -100.0% | 539 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -100.0% | 539 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 539 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -33.3% | 539 | 0.0% | 0.00% | – |
Q1 2022 | $3,000 | -57.1% | 539 | 0.0% | 0.00% | – |
Q4 2021 | $7,000 | -36.4% | 539 | -14.4% | 0.00% | – |
Q3 2021 | $11,000 | +83.3% | 630 | +74.5% | 0.00% | – |
Q2 2021 | $6,000 | -14.3% | 361 | 0.0% | 0.00% | – |
Q1 2021 | $7,000 | +16.7% | 361 | +7.1% | 0.00% | – |
Q4 2020 | $6,000 | -62.5% | 337 | -66.1% | 0.00% | – |
Q3 2020 | $16,000 | -11.1% | 993 | 0.0% | 0.00% | – |
Q2 2020 | $18,000 | 0.0% | 993 | 0.0% | 0.00% | – |
Q1 2020 | $18,000 | -14.3% | 993 | 0.0% | 0.00% | – |
Q4 2019 | $21,000 | -85.2% | 993 | -87.3% | 0.00% | -100.0% |
Q3 2019 | $142,000 | -45.2% | 7,820 | +7.6% | 0.00% | -50.0% |
Q2 2019 | $259,000 | +5.7% | 7,270 | -0.3% | 0.00% | 0.0% |
Q1 2019 | $245,000 | +2.1% | 7,294 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $240,000 | -44.1% | 7,294 | +3.5% | 0.00% | -50.0% |
Q3 2018 | $429,000 | +34.1% | 7,044 | +7.6% | 0.00% | +33.3% |
Q2 2018 | $320,000 | +188.3% | 6,544 | +527.4% | 0.00% | +200.0% |
Q1 2018 | $111,000 | – | 1,043 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
CM Management, LLC | 50,000 | $858,000 | 0.62% |
Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |